Akebia Therapeutics, Inc.AKBANASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Over Time
Trending lower, below historical average.
Left:
||||
Revenue minus cost of goods sold
Latest
$97.00M
↓ 25% below average
Average (9y)
$130.10M
Historical baseline
Range
High:$269.99M
Low:$-114.25M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $97.00M | -19.5% |
| 2023 | $120.47M | -55.4% |
| 2022 | $269.99M | +107.4% |
| 2021 | $130.16M | -43.6% |
| 2020 | $230.68M | +21.6% |
| 2019 | $189.66M | -5.2% |
| 2018 | $200.06M | +12.8% |
| 2017 | $177.37M | +255.2% |
| 2016 | $-114.25M | -118910.4% |
| 2015 | $-96000.00 | - |